8th February 2016 Content supplied by: ELITechGroup
Collaboration Expands ELITe InGenius™ Menu of Infectious Disease Assays
ELITechGroup and Fast-track diagnostics group have announced a worldwide agreement to extend the ELITe InGenius menu with a wide range of qualitative multiplex real-time PCR assays for the in vitro diagnostic of infectious diseases.
Under this agreement, Fast-track diagnostics will manufacture qualitative multiplex panels for ELITechGroup related to various clinical applications complementary to the existing ELITE InGenius core menu focus on transplant monitoring and healthcare acquired infections. Global commercialization of the upcoming CE-IVD assays in combination with ELITe InGenius is ensured by ELITechGroup subsidiaries and affiliates through a worldwide distributor’s network.
ELITe InGenius is a fully automated cassette-based, sample-to-result solution which automatically performs all the steps of Molecular Diagnostics with unrivaled flexibility enabling laboratories to run CE-IVD assays, as well as laboratory developed tests or other tests of interest simply on demand while streamlining their workflow.
“We are very pleased to establish a partnership with Fast-track diagnostics to quickly expand the ELITe InGenius menu to new application fields leveraging the unique capabilities of our integrated system” said Christoph Gauer, CEO of ELITechGroup. “Aligned with our strategy, this agreement enables us to complete the unique ELITe InGenius proprietary portfolio, based on quantitative applications, with qualitative multiplexed panels to offer laboratories a total solution for infectious disease testing with an unequalled CE-IVD menu.”
Bill Carman, CEO of Fast-track diagnostics, commented: “Fast-track diagnostics is delighted to be collaborating with ELITechGroup. We are dedicated to developing high-quality, accurate multiplex PCR panels and look forward to working with the ELITechGroup team to develop a range of tests for the ELITe InGenius system.”
Date Published: 8th February 2016
Source article link: View